Hypoadiponectinemia, elevated iron and high-sensitivity C-reactive protein levels and their relation with prostate size in benign prostatic hyperplasia

被引:7
|
作者
Nandeesha, H. [1 ]
Eldhose, A. [1 ]
Dorairajan, L. N. [1 ]
Anandhi, B. [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res, Dept Biochem & Urol, Pondicherry, India
关键词
adiponectin; benign prostatic hyperplasia; C-reactive protein; iron; prostate-specific antigen; SERUM ADIPONECTIN; CANCER; TISSUE; RISK;
D O I
10.1111/and.12715
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Elevated iron, high-sensitivity C-reactive protein (CRP) and hypoadiponectinemia are known to initiate tumour development. There is paucity of data regarding the above-mentioned parameters and their relation with prostate size in benign prostatic hyperplasia (BPH). The present study was designed to assess the levels of iron, hs-CRP and adiponectin levels and their association with prostate size in BPH patients. A total of 37 BPH cases and 36 controls were enrolled in the study. Iron, hs-CRP and adiponectin were estimated in both the groups. Iron and hs-CRP were significantly increased and adiponectin was significantly reduced in BPH cases when compared with controls. Iron (r=.397, p=.015), hs-CRP (r=.341, p=.039) and adiponectin (r=-.464, p=.004) were significantly associated with prostate size in BPH cases. Multivariate linear regression analysis showed that iron acts as predictor of prostate size in BPH (R-2 = 0.395, beta = 0.526, p=.001). We conclude that iron and hs-CRP are elevated and adiponectin is reduced in BPH cases and associated with prostate size.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Association of Elevated Levels of Inflammatory Marker High-Sensitivity C-Reactive Protein and Hypertension
    Bisaria, Sharmila
    Terrigno, Vittorio
    Hunter, Krystal
    Roy, Satyajeet
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2020, 11
  • [2] Comparison of C-Reactive Protein and High-Sensitivity C-Reactive Protein Levels in Patients on Hemodialysis
    Helal, Imed
    Zerelli, Lilia
    Krid, Madiha
    ElYounsi, Fethi
    Ben Maiz, Hedi
    Zouari, Bechir
    Adelmoula, Jaouida
    Kheder, Adel
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2012, 23 (03) : 477 - 483
  • [3] High-sensitivity C-reactive protein levels in obese women
    Dharmalingam, Mala
    Dev, Nirmitha
    Marcus, Sara Rani
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S98 - S99
  • [4] High-Sensitivity C-Reactive Protein Levels and Cancer Mortality
    Ko, Young-Jin
    Kwon, Young-Min
    Kim, Kyae Hyung
    Choi, Ho-Chun
    Chun, So Hyun
    Yoon, Hyung-Jin
    Goh, Eurah
    Cho, Belong
    Park, Minseon
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (11) : 2076 - 2086
  • [5] C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians
    Windgassen, Elizabeth B.
    Funtowicz, Luciana
    Lunsford, Tisha N.
    Harris, Lucinda A.
    Mulvagh, Sharon L.
    POSTGRADUATE MEDICINE, 2011, 123 (01) : 114 - 119
  • [6] Statin therapy inhibits neointimal hyperplasia after coronary stenting in patients with elevated preprocedural high-sensitivity C-reactive protein levels
    Hong, YJ
    Jeong, MH
    Kim, W
    Kim, JH
    Cho, JG
    Park, JC
    Kang, JC
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 152H - 152H
  • [7] Food intake and high-sensitivity C-reactive protein levels in adolescents
    Cabral, M.
    Araujo, J.
    Lopes, C.
    Ramos, E.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (10) : 1067 - 1074
  • [8] High-Sensitivity C-Reactive Protein and Cancer
    Lee, Seounghee
    Choe, Jae-Won
    Kim, Hong-Kyu
    Sung, Joohon
    JOURNAL OF EPIDEMIOLOGY, 2011, 21 (03) : 161 - 168
  • [9] What is high-sensitivity C-reactive protein?
    Conti, CR
    CLINICAL CARDIOLOGY, 2001, 24 (10) : 639 - 640
  • [10] High-sensitivity C-reactive protein in psoriasis
    Nisa, Nuzhatun
    Ahmed, Qazi
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (11) : 1393 - 1394